Introductory Clause Example with Variations from Business Contracts

This page contains Introductory clauses in business contracts and legal agreements. An example clause is provided at the top of the page, followed by clauses with minor variations. You can view the text differences by selecting the "Show Differences" option.
Introductory. Corvus Pharmaceuticals, Inc., a Delaware corporation ("Company"), agrees with the several Underwriters named in Schedule A hereto ("Underwriters"), for whom Credit Suisse Securities (USA) LLC and Cowen and Company, LLC are acting as representatives ("Representatives"), to issue and sell to the several Underwriters shares ("Firm Securities") of its common stock, par value $0.0001 per share ("Securities") and also proposes to issue and sell to the Underwriters, at the option of the Underwriters,... an aggregate of not more than additional shares ("Optional Securities") of its Securities as set forth below. The Firm Securities and the Optional Securities are herein collectively called the "Offered Securities". View More Arrow
Found in Corvus Pharmaceuticals, Inc. contract

Variations of a "Introductory" Clause from Business Contracts

Introductory. Corvus Pharmaceuticals, Parsley Energy, Inc., a Delaware corporation ("Company"), (the "Company") agrees with Morgan Stanley & Co. LLC (the "Representative"), as representative of the several Underwriters named in Schedule A hereto ("Underwriters"), for whom Credit Suisse Securities (USA) LLC and Cowen and Company, LLC are acting as representatives ("Representatives"), (the "Underwriters"), to issue and sell to the several Underwriters 18,250,000 shares ("Firm (the "Firm Securities") of its the... Company's Class A common stock, par value $0.0001 $0.01 per share ("Securities") and (the "Securities") on the terms set forth in this agreement (this "Agreement"). The Company also proposes agrees to issue and sell to the Underwriters, at the option of the Underwriters, an aggregate of not more than 2,737,500 additional shares ("Optional Securities") of its Securities (the "Optional Securities") as set forth in Section 3 below. The Firm Securities and the Optional Securities are herein collectively called the "Offered Securities". Certain terms used in this Agreement are defined in Section 2(i) hereof. View More Arrow
Found in Parsley Energy, Inc. contract
Introductory. Corvus Pharmaceuticals, Parsley Energy, Inc., a Delaware corporation ("Company"), (the "Company") agrees with J.P. Morgan Securities LLC (the "Representative"), as representative of the several Underwriters named in Schedule A hereto ("Underwriters"), for whom Credit Suisse Securities (USA) LLC and Cowen and Company, LLC are acting as representatives ("Representatives"), (the "Underwriters"), to issue and sell to the several Underwriters 7,250,000 shares ("Firm (the "Firm Securities") of its the Company's Class A common stock, par value $0.0001 $0.01 per share ("Securities") and (the "Securities"), on the terms set forth in this agreement (this "Agreement"). The Company also proposes agrees to issue and sell to the Underwriters, at the option of the Underwriters, an aggregate of not more than 1,087,500 additional shares ("Optional Securities") of its Securities (the "Optional Securities") as set forth in Section 3 below. The Firm Securities and the Optional Securities are herein collectively called the "Offered Securities". Certain terms used in this Agreement are defined in Section 2(i) hereof. View More Arrow
Found in Parsley Energy, Inc. contract
Introductory. Corvus Pharmaceuticals, Parsley Energy, Inc., a Delaware corporation ("Company"), (the "Company") agrees with Credit Suisse Securities (USA) LLC (the "Representative"), as representative of the several Underwriters named in Schedule A hereto ("Underwriters"), for whom Credit Suisse Securities (USA) LLC and Cowen and Company, LLC are acting as representatives ("Representatives"), (the "Underwriters"), to issue and sell to the several Underwriters 8,250,000 shares ("Firm (the "Firm Securities")... of its the Company's Class A common stock, par value $0.0001 $0.01 per share ("Securities") and (the "Securities") on the terms set forth in this agreement (this "Agreement"). The Company also proposes agrees to issue and sell to the Underwriters, at the option of the Underwriters, an aggregate of not more than 1,237,500 additional shares ("Optional Securities") of its Securities (the "Optional Securities") as set forth in Section 3 below. The Firm Securities and the Optional Securities are herein collectively called the "Offered Securities". Certain terms used in this Agreement are defined in Section 2(i) hereof. View More Arrow
Found in Parsley Energy, Inc. contract
Introductory. Corvus Pharmaceuticals, Parsley Energy, Inc., a Delaware corporation ("Company"), (the "Company") agrees with Credit Suisse Securities (USA) LLC (the "Representative"), as representative of the several Underwriters named in Schedule A hereto ("Underwriters"), for whom Credit Suisse Securities (USA) LLC and Cowen and Company, LLC are acting as representatives ("Representatives"), (the "Underwriters"), to issue and sell to the several Underwriters 36,000,000 shares ("Firm (the "Firm Securities")... of its the Company's Class A common stock, par value $0.0001 $0.01 per share ("Securities") and (the "Securities"), on the terms set forth in this agreement (this "Agreement"). The Company also proposes agrees to issue and sell to the Underwriters, at the option of the Underwriters, an aggregate of not more than 5,400,000 additional shares ("Optional Securities") of its Securities (the "Optional Securities") as set forth in Section 3 below. The Firm Securities and the Optional Securities are herein collectively called the "Offered Securities". Certain terms used in this Agreement are defined in Section 2(i) hereof. View More Arrow
Found in Parsley Energy, Inc. contract
Introductory. Corvus Pharmaceuticals, The RealReal, Inc., a Delaware corporation ("Company"), ("Company") agrees with the several Underwriters named in Schedule A hereto ("Underwriters"), for whom Credit Suisse Securities (USA) LLC and Cowen and Company, LLC are acting as representatives ("Representatives"), ("Underwriters") to issue and sell to the several Underwriters [ ] shares ("Firm Securities") of its common stock, par value $0.0001 per share ("Securities") and stock (the "Firm Securities"). The... Company also proposes agrees to issue and sell to the Underwriters, at the option of the Underwriters, an aggregate of not more than [ ] additional shares ("Optional Securities") of its Securities (such additional shares of securities to be sold by the Company, "Optional Securities"), as set forth below. The Firm Securities and the Optional Securities are herein collectively called the "Offered Securities". View More Arrow
Found in TheRealReal, Inc. contract
Introductory. Corvus Pharmaceuticals, Endocyte, Inc., a Delaware corporation ("Company"), (the "Company"), agrees with the several Underwriters named in Schedule A hereto ("Underwriters"), for whom Credit Suisse Securities (USA) LLC and Cowen and Company, LLC are acting as representatives ("Representatives"), (the "Underwriters") to issue and sell to the several Underwriters 4,500,000 shares ("Firm (the "Firm Securities") of its common stock, par value $0.0001 $0.001 per share ("Securities") (the... "Securities"), and also proposes to issue and sell to the Underwriters, at the option of the Underwriters, an aggregate of not more than 675,000 additional shares ("Optional (the "Optional Securities") of its Securities as set forth below. The Firm Securities and the Optional Securities are herein collectively called the "Offered Securities". View More Arrow
Found in ENDOCYTE INC contract
Introductory. Corvus Pharmaceuticals, Inc., Synergy Resources Corporation, a Delaware Colorado corporation ("Company"), agrees with the several Underwriters named in Schedule A hereto ("Underwriters"), for whom Credit Suisse Securities (USA) LLC and Cowen and Company, LLC are acting as representatives ("Representatives"), ("Underwriters") to issue and sell to the several Underwriters 19,500,000 shares ("Firm Securities") of its common stock, par value $0.0001 $0.001 per share ("Securities") ("Securities"),... and also proposes to issue and sell to the Underwriters, at the option of the Underwriters, an aggregate of not more than 2,925,000 additional shares ("Optional Securities") of its Securities as set forth below. The Firm Securities and the Optional Securities are herein collectively called the "Offered Securities". View More Arrow
Found in SRC Energy Inc. contract
Introductory. Corvus Pharmaceuticals, Entasis Therapeutics Holdings Inc., a Delaware corporation ("Company"), (the "Company"), agrees with the several Underwriters named in Schedule A hereto ("Underwriters"), (the "Underwriters"), for whom Credit Suisse Securities (USA) LLC and Cowen and Company, LLC BMO Capital Markets Corp. are acting as representatives ("Representatives"), (the "Representatives"), to issue and sell to the several Underwriters [ ] shares ("Firm (the "Firm Securities") of its common stock,... par value $0.0001 $0.001 per share ("Securities") and (the "Securities"). The Company also proposes agrees to issue and sell to the Underwriters, at the option of the Underwriters, an aggregate of not more than [ ] additional shares ("Optional Securities") of its Securities as set forth below. (the "Optional Securities"). The Firm Securities and the Optional Securities are herein collectively called the "Offered Securities". View More Arrow
Found in Entasis Therapeutics Holdings Inc. contract
Introductory. Corvus Pharmaceuticals, Inc., Synergy Resources Corporation, a Delaware Colorado corporation ("Company"), agrees with the several Underwriters named in Schedule A hereto ("Underwriters"), for whom Credit Suisse Securities (USA) LLC and Cowen and Company, LLC are acting as representatives ("Representatives"), ("Underwriters") to issue and sell to the several Underwriters 45,000,000 shares ("Firm Securities") of its common stock, par value $0.0001 $0.001 per share ("Securities") ("Securities"),... and also proposes to issue and sell to the Underwriters, at the option of the Underwriters, an aggregate of not more than 6,750,000 additional shares ("Optional Securities") of its Securities as set forth below. The Firm Securities and the Optional Securities are herein collectively called the "Offered Securities". View More Arrow
Found in SRC Energy Inc. contract
Introductory. Corvus Pharmaceuticals, XenoPort, Inc., a Delaware corporation ("Company"), agrees with the several Underwriters named in Schedule A hereto ("Underwriters"), for whom Credit Suisse Securities (USA) LLC and Cowen and Company, LLC are acting as representatives ("Representatives"), ("Underwriters") to issue and sell to the several Underwriters 12,000,000 shares ("Firm Securities") of its common stock, par value $0.0001 $0.001 per share ("Securities") ("Common Stock"), and also proposes to issue... and sell to the Underwriters, at the option of the Underwriters, an aggregate of not more than 1,800,000 additional shares ("Optional Securities") of its Securities Common Stock as set forth below. The Firm Securities and the Optional Securities are herein collectively called the "Offered Securities". View More Arrow
Found in XENOPORT INC contract